Theophylline

Product NDC
62332-026
11-digit product format
623320026
Labeler code
62332
Product ID
62332-026_d9cbb2b7-6524-4587-9111-e3abfd2e888b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Theophylline
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Alembic Pharmaceuticals Inc.
Application
ANDA090430
Marketing category
ANDA
Marketing start
2016-01-29
Substance
THEOPHYLLINE ANHYDROUS
Active strength
450 mg/1
Pharmacologic classes
Methylxanthine [EPC], Xanthines [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A090430-001THEOPHYLLINETHEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27
A090430-002THEOPHYLLINETHEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A090430-001AB
A090430-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27caaa826d4ba7…
2026-08-18 06:07:402026-07A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-2731067a03dcf5…
2025-08-23 18:47 UTC2025-08A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-276a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-2703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-272680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-275bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27d06236e962d9…
2024-10-29 15:01 UTC2024-10A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-2779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-2779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-271e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-271e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-278072bd15b7f6…
2024-05-31 18:47 UTC2024-05A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-278072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-275c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-275c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-275d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-275d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-274b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-274b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-2774a2ff9319b5…
2019-12-13 00:20 UTC2019-12A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALRS2010-10-2774a2ff9319b5…
2022-03-09 01:35 UTC2022-03A090430-001THEOPHYLLINE300MGTABLET, EXTENDED RELEASE / ORALAB2010-10-27bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A090430-002THEOPHYLLINE450MGTABLET, EXTENDED RELEASE / ORALABRS2010-10-27bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 72 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A090430-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A090430-002AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A090430-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A090430-002AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090430-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A090430-002AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A090430-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A090430-002AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090430-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A090430-002AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090430-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A090430-002AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090430-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A090430-002AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090430-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A090430-002AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090430-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A090430-002AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090430-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A090430-002AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A090430-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A090430-002AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090430-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A090430-002AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090430-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A090430-002AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090430-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A090430-002AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A090430-001AB18072bd15b7f6…
2024-05-31 18:47 UTC2024-05A090430-002AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090430-001AB15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A090430-002AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A090430-001AB15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A090430-002AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A090430-001AB14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A090430-002AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A090430-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A090430-001AB1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A090430-002AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A090430-001AB1782e0a99824c…

Additional Listing Data#

Finished product
Yes
Brand name base
Theophylline
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
THEOPHYLLINE ANHYDROUS450 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
0I55128JYKInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
314241Internal RxNorm lookup
317769Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
77e849b8-900b-4f0d-ac5c-1391abcd5721Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
d1d07c79-5983-427d-b6f5-df0550dcc598Product name420250325
7b1e3dc0-e6b1-4d5d-943b-99fdd948b5a2Product name120170302

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62332-026-30Theophylline30 in 1 BOTTLETABLET, EXTENDED RELEASE306
62332-026-31Theophylline100 in 1 BOTTLETABLET, EXTENDED RELEASE1006
62332-026-71Theophylline500 in 1 BOTTLETABLET, EXTENDED RELEASE5006

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62332-026-31EA - Each62332-02647f3f49d-1dc5-45ab-8e17-06bf7cf889d912016-04-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
62332-026THEOPHYLLINE TABLET, EXTENDED RELEASE [ALEMBIC PHARMACEUTICALS INC.]6Current NDC, Legacy NDC, 3 package rows20211008_77e849b8-900b-4f0d-ac5c-1391abcd5721.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TheophyllineTHEOPHYLLINEAlembic Pharmaceuticals Limited31f3c720-1597-4d43-9296-33017b90b15f2023-01-11Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090430
application number: ANDA090430
TheophyllineTHEOPHYLLINEAlembic Pharmaceuticals Inc.77e849b8-900b-4f0d-ac5c-1391abcd57212021-10-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 090430
application number: ANDA090430
ndc (product): 62332-026

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
317769theophylline 300 MG Extended Release Oral TabletPSN77e849b8-900b-4f0d-ac5c-1391abcd57216
314241theophylline 450 MG Extended Release Oral TabletPSN77e849b8-900b-4f0d-ac5c-1391abcd57216
317769theophylline 300 MG Extended Release Oral TabletSCD77e849b8-900b-4f0d-ac5c-1391abcd57216
314241theophylline 450 MG Extended Release Oral TabletSCD77e849b8-900b-4f0d-ac5c-1391abcd57216

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
62332-026-306233200263030 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-30) 2016-01-290000-00-00NoNoCurrent
62332-026-3162332002631100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-31) 2016-01-290000-00-00NoNoCurrent
62332-026-7162332002671500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-026-71) 2016-01-290000-00-00NoNoCurrent